Reframing Rehabilitation for Knee Osteoarthritis and Replacement Patients

## Understanding Arthrogenic Muscle Inhibition Arthrogenic muscle inhibition (AMI) is a reflexive inhibition of muscles around an injured or operated joint, commonly affecting the quadriceps. This inhibition is not due to lack of effort, pain tolerance, or motivation, but rather to neurophysiological mechanisms that alter joint signaling, spinal reflexes, and motor cortex activity, limiting muscle mobilization even at maximal effort. ## A Multi-Level Problem AMI can be conceptualized as a multi-level process, with inhibition occurring across three interconnected physiological levels: peripheral, spinal, and supraspinal. Each level contributes to the impaired voluntary muscle activation seen clinically. For example, even minimal joint effusion can significantly impede quadriceps activation, making swelling control a crucial neurophysiological intervention. ## Why Standard Rehab May Under-Deliver Current rehabilitation approaches, such as range-of-motion exercises and progressive strengthening, may not be sufficient to address AMI. These interventions may depend on a neurologically restricted system, leading to an 'activation debt' and persistent compensatory patterns. Neglecting to address this window can result in quadriceps deficits of 20-40% that may persist for months or even years. ## A Staged, Mechanism-Led Rehabilitation Framework The authors propose a staged, mechanism-led rehabilitation framework to address AMI. This framework includes: * Days 0-7: Break the effusion-inhibition loop using cryotherapy, compression, elevation, early activation, and neuromuscular electrical stimulation (NMES). * Weeks 1-3: Restore voluntary drive using higher-intensity NMES, EMG/pressure biofeedback, terminal-extension quality work, and motor imagery/action observation. * Weeks 2-8: Bridge with blood flow restriction training (BFRT) to enable meaningful strength gains at low loads. * Weeks 4-10: Sensorimotor retraining using balance, perturbation training, and dual-task work to rebuild reactive control and coordination. * Weeks 8-16+: High-level motor control using power, eccentric stair-descent capacity, gait symmetry with feedback, and task-specific demands. ## Effective Treatment Requires Accurate Measurement A major barrier in rehabilitation is the lack of routine measurement of voluntary activation. The authors recommend reporting the central activation ratio (CAR) alongside validated EMG-based metrics and functional outcomes to enable more targeted rehabilitation. ## Take-Home Messages for Clinicians For physiotherapists and rehabilitation clinicians managing patients after knee osteoarthritis or knee arthroplasty, the review suggests the following key actions: * Treat effusion as a neurological problem and control it aggressively and early. * Start NMES early, rather than waiting for 'enough' voluntary activation. * Use BFRT as a bridge when high loads aren't tolerated. * Go beyond strength and retrain coordination, gait extension, and address cortical/psychological layers. * Measure activation, not just range and reps. * Consider AMI before surgery, too, as prehabilitation may lower the baseline inhibition you start from post-operatively. ## Conclusion By reframing AMI as a primary, measurable target, clinicians can adopt a coherent, mechanism-based approach to improve strength, gait, and patient satisfaction following knee osteoarthritis and knee replacement. While the structural issue may be resolved, the focus must shift to restoring neuromuscular connectivity.